The kidney transplant market involves the transplantation of kidneys from live or deceased donors to patients suffering from end-stage renal disease. Kidney transplantation is currently the most effective treatment for end-stage kidney failure as the transplanted organ can have a functioning life of up to 20 years. The procedure reduces risks associated with dialysis and improves quality of life of patients. Factors such as rising prevalence of diabetes and hypertension leading to chronic kidney disease, growing awareness about organ donation and transplantation, and technological advancements are fueling the growth of this market.
The Global Kidney Transplant Market is estimated to be valued at US$ 99,232.33 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the kidney transplant market are Alumasc Group Plc, Binderholz GmbH, Bauder Ltd, Forbo International SA, Certain Teed Corporation, The Turner Corp, Clark Group, Gilbane Building Co, Hensel Phelps, The Whiting-Turner Contracting Co. The kidney transplant procedures have increased globally with the United States recording the highest number of kidney transplants annually. As per the data by United Network for Organ Sharing, in 2020, there were 21,167 kidney transplants performed in the US. The growing prevalence of lifestyle diseases such as diabetes and hypertension leading to kidney failures has boosted the demand for kidney transplantation procedures worldwide. Various technological advancements such as use of laparoscopic and robotic techniques for donor nephrectomy and improvements in immunosuppressive drug therapies have improved outcomes of kidney transplantations.
Market Trends
Increasing Living Donors: There is a growing trend of living organ donation owing to shortage of organ donors. This is driven by ethical campaigns promoting organ donation. Advanced Imaging Technologies: Novel imaging technologies help evaluate kidney function pre-operatively and aid in selecting suitable donors and recipients improving outcomes. Combination Therapy: Combination of immunosuppressant drugs with steroid-free protocols after transplantation is becoming popular to prevent side-effects of individual drugs.
Market Opportunities
Rising Healthcare Expenditure in Emerging Nations: Countries like India and China are witnessing increased healthcare spending that will boost transplantation facilities and procedures. Cell Therapies: Mesenchymal stem cell therapies and techniques like tolerance induction show potential to minimize immunosuppression after transplantation in future.
Impact of COVID-19 on Kidney Transplant Market
The COVID-19 pandemic has impacted the growth of the Kidney Transplant Market Demand During the initial months of the pandemic in 2020, elective surgeries like organ transplants were postponed or canceled to reduce strain on healthcare resources and minimize risk of infection to patients with compromised immunity. This led to a decline in the number of kidney transplants performed worldwide. However, transplant being a life-saving procedure, healthcare systems aimed to fast track emergency transplants. With relaxation of restrictions and implementation of proper safety protocols in hospitals and clinics, transplant numbers recovered gradually post the first wave of COVID-19. But new variants and recurring waves continue to pose challenges. The shortage of organ donors during the pandemic periods has also affected market growth. On the positive side, greater focus on technology, virtual consults, dedicated COVID-free hospitals and vaccination drives for transplant patients are helping restore market momentum. Innovation in immunosuppressant drugs and surgical techniques also support long term growth opportunities. Strict adherence to safety standards will be vital in maintaining a steady increase in transplant volumes worldwide in the coming years.
In terms of regional market value concentration, North America leads currently due to advanced healthcare facilities, high treatment costs and growing aging population with kidney diseases. Europe follows next in terms of overall kidney transplant procedures. The Asia Pacific market is primed to be the fastest growing driven by accelerating healthcare investments, rising medical tourism and increasing awareness around organ donation in nations like India, China and South Korea. Growing investment in transplant infrastructure and programs across emerging countries of the Middle East and Latin America also indicate lucrative prospects over the forecast period.
Get more insights, On Kidney Transplant Market
